Just to get this thread back on track. Can I suggest the following. If the thread title is social media can we stick to those type of posts and discussions directly related to them. If you want to discuss video etc make a separate thread. When we do our research it is a lot easier to go through the thread when we don't have to skip past videos and then the insults etc that follow.
It seems Roby has been very active in regards to twitter. There was some really good to and fro. Someone quizzed him on the payment for directors. This was a good exchange.
However the ones that interested me was references he made to the FDA approval process and clinical trials. He then posted discussions around dementia. Dementia was frequently mentioned in the last investor presentation. Although I couldn't find an obvious connection between their scientific connections and dementia. Maybe somebody else could?
Could it be the delivery systems were for a new pharma product in the field of Dementia which is going to undergo clinical trials? Could it be that cannepil is being fast tracked through the FDA approval system?
MXC Price at posting:
5.5¢ Sentiment: Buy Disclosure: Held
